Areas of Focus
- Mechanisms of uterine NK cells in promoting early embryonic development
- Transcriptional regulation of NK cells and disease mechanisms
- Immunotherapy targeting reproductive immune microenvironment for pregnancy-related diseases
Work Experience
- 2018-2020 - University of Science and Technology of China, School of Life Sciences and Medicine, Postdoctoral Researcher
- 2018-2021 - University of Science and Technology of China, School of Life Sciences and Medicine, Special Associate Researcher
Academic Background & Achievements
- 2018 - PhD in Immunology: University of Science and Technology of China
- 2020 - Awarded 'Outstanding Doctoral Dissertation' by the Chinese Academy of Sciences
- 2020 - Received 'Anhui Youth May Fourth Medal'
- 2020 - Selected as 'Mozi Outstanding Youth' at USTC
Publications
- PBX1 expression in uterine natural killer cells drives fetal growth., Zhou Y, Fu B, Xu X, Zhang J, Tong X, Wang Y, Dong Z, Zhang X, Shen N, Zhai Y, Kong X, Sun R, Tian Z, Wei H., 2020
- Natural killer cells promote fetal development through the secretion of growth-promoting factors., Fu B#, Zhou Y#, Ni X#, Tong X, Xu X, Dong Z, Sun R, Tian Z, Wei H., 2017
- Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients., Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, Sun R, Tian Z, Xu X, Wei H., 2020
- Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status., Zhou Y, Zhang J, Wang D, Guan W, Qin J, Xu X, Fang J, Fu B, Zheng X, Wang D, Zhao H, Chen X, Tian Z, Xu X, Wang G, Wei H., 2021
- Tocilizumab is recommended for the treatment of severe COVID-19., Zhou Y, Wei H., 2020
Awards
- 2020: Anhui Youth May Fourth Medal
- 2020: Outstanding Doctoral Dissertation by the Chinese Academy of Sciences
- 2020: Mozi Outstanding Youth at USTC